Skip to Content

TEVA 5550 (Dexmethylphenidate hydrochloride extended-release 5 mg)

Pill imprint TEVA 5550 has been identified as Dexmethylphenidate hydrochloride extended-release 5 mg.

Dexmethylphenidate is used in the treatment of auditory processing disorder; adhd and belongs to the drug class CNS stimulants. Risk cannot be ruled out during pregnancy. Dexmethylphenidate 5 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Dexmethylphenidate hydrochloride extended-release 5 mg TEVA 5550
Discount Card Promo
Dexmethylphenidate hydrochloride extended-release
Imprint:
TEVA 5550
Strength:
5 mg
Color:
Blue
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Manufacturer:
Teva Pharmaceuticals USA Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide